secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2022-01-14T23:59:59+00:00
Accession:  0000310764-22-000003
Event type: other
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker realigns into MedSurg/Neurotechnology and Orthopaedics/Spine segments effective Dec 31, 2021
--------------------------------------------------------------------------------

- Segments reflect new internal structure after COO transition; Pierce leads MedSurg/Neuro, Stiles leads Ortho/Spine.
- FY 2021 recast sales: MedSurg/Neuro $8,345M, Ortho/Spine $6,006M, total $14,351M.
- Q4 2021 recast sales: MedSurg/Neuro $2,429M, Ortho/Spine $1,833M, total $4,262M.
- Exhibit 99.1 provides recast historical sales for 2019, 2020, and full-year 2021.
- Change aligns with previously announced management responsibilities transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076422000003/0000310764-22-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076422000003/syk-20220114.htm
  HTML page:      https://secwatch.observer/filing/0000310764-22-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer